The Effectiveness and Feasibility of Using Antiviral Therapy in Pregnant Women to Reduce Mother-to-infant Transmission of Hepatitis B Virus-drug Test.

Trial Profile

The Effectiveness and Feasibility of Using Antiviral Therapy in Pregnant Women to Reduce Mother-to-infant Transmission of Hepatitis B Virus-drug Test.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 29 Oct 2015

At a glance

  • Drugs Tenofovir disoproxil fumarate (Primary)
  • Indications Hepatitis B
  • Focus Therapeutic Use
  • Most Recent Events

    • 26 Oct 2015 Planned End Date changed from 1 Dec 2014 to 1 Dec 2018, according to ClinicalTrials.gov record.
    • 26 Oct 2015 Planned primary completion date changed to 1 Dec 2017, according to ClinicalTrials.gov record.
    • 26 Oct 2015 Status changed from active, no longer recruiting to recruiting, according to ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top